{"id":"methapyrilene","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Angle-closure glaucoma","Benign prostatic hyperplasia","Bladder outflow obstruction","Chronic idiopathic constipation","Hypertensive disorder","Hyperthyroidism","Ocular hypertension","Peptic ulcer","Retention of urine"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":[],"patents":[],"pricing":[],"_fixedAt":"2026-03-30T14:28:00.982852","_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=METHAPYRILENE","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T02:34:16.658858+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T02:34:28.222298+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=METHAPYRILENE","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T02:34:28.990746+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1411979/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T02:34:29.459531+00:00"}},"allNames":"thenylene","offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2B","modality":"Small Molecule"},"_scrapedAt":"2026-03-28T00:33:51.955Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:34:31.344507+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"indications":{"approved":[{"name":"Allergic conjunctivitis","diseaseId":"allergic-conjunctivitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Allergic rhinitis","diseaseId":"allergic-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Anaphylaxis Adjunct","diseaseId":"anaphylaxis-adjunct","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Dermatographic urticaria","diseaseId":"dermatographic-urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Itching of skin","diseaseId":"itching-of-skin","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nasal congestion","diseaseId":"nasal-congestion","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Nasal discharge","diseaseId":"nasal-discharge","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Sneezing","diseaseId":"sneezing","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Urticaria","diseaseId":"urticaria","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Vasomotor rhinitis","diseaseId":"vasomotor-rhinitis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"_fixedFields":["modality→Small Molecule"],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06003062","phase":"","title":"Suppression of Upper Lip Hair Growth Using Novel Hemp Extract","status":"UNKNOWN","sponsor":"Medical Life Care Planners, LLC","startDate":"2023-09-01","conditions":"Hirsutism, Hair Diseases","enrollment":25}],"_emaApprovals":[],"_faersSignals":[{"count":2,"reaction":"AGGRESSION"},{"count":2,"reaction":"ANXIETY"},{"count":2,"reaction":"DEPRESSION"},{"count":2,"reaction":"DISTURBANCE IN ATTENTION"},{"count":2,"reaction":"FATIGUE"},{"count":2,"reaction":"INSOMNIA"},{"count":2,"reaction":"MEMORY IMPAIRMENT"},{"count":2,"reaction":"MENTAL DISORDER"},{"count":2,"reaction":"PANIC ATTACK"},{"count":2,"reaction":"SELF ESTEEM DECREASED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"chemblId":"CHEMBL1411979"},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":223,"therapeuticAreas":["Dermatology"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"withdrawn","brandName":"Thenylene","genericName":"METHAPYRILENE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T02:34:31.344507+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}